Frederick G. Behm

10.6k total citations · 3 hit papers
98 papers, 7.6k citations indexed

About

Frederick G. Behm is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Frederick G. Behm has authored 98 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Public Health, Environmental and Occupational Health, 46 papers in Hematology and 22 papers in Molecular Biology. Recurrent topics in Frederick G. Behm's work include Acute Lymphoblastic Leukemia research (48 papers), Acute Myeloid Leukemia Research (30 papers) and Lymphoma Diagnosis and Treatment (21 papers). Frederick G. Behm is often cited by papers focused on Acute Lymphoblastic Leukemia research (48 papers), Acute Myeloid Leukemia Research (30 papers) and Lymphoma Diagnosis and Treatment (21 papers). Frederick G. Behm collaborates with scholars based in United States, United Kingdom and Canada. Frederick G. Behm's co-authors include Susana C. Raimondi, Ching‐Hon Pui, Gaston K. Rivera, Dario Campana, Jeffrey E. Rubnitz, John T. Sandlund, Raul C. Ribeiro, Michael L. Hancock, Elaine Coustan‐Smith and James R. Downing and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Frederick G. Behm

98 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

2009 616 citations Elaine Coustan‐Smith, Charles G. Mullighan et al. The Lancet Oncology profile →
The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB–binding protein

1996 603 citations Frederick G. Behm et al. profile →
Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia

1991 523 citations Ching‐Hon Pui, Raul C. Ribeiro et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frederick G. Behm United States	43	3.8k	3.7k	2.1k	1.7k	1.5k	98	7.6k
Keizo Horibe Japan	45	2.7k 0.7×	3.1k 0.9×	1.4k 0.7×	1.5k 0.9×	1.6k 1.0×	282	6.7k
Vincent H. J. van der Velden Netherlands	45	3.8k 1.0×	5.1k 1.4×	2.4k 1.2×	1.0k 0.6×	1.4k 0.9×	168	8.5k
Charlotte M. Niemeyer Germany	54	2.0k 0.5×	4.8k 1.3×	4.1k 2.0×	976 0.6×	1.6k 1.0×	260	10.3k
Franklin O. Smith United States	37	1.8k 0.5×	2.9k 0.8×	1.5k 0.7×	877 0.5×	1.2k 0.8×	121	5.3k
Kristen E. Stevenson United States	35	1.5k 0.4×	3.4k 0.9×	1.9k 0.9×	1.1k 0.7×	1.4k 0.9×	128	7.2k
Mathias Freund Germany	34	1.4k 0.4×	2.3k 0.6×	1.6k 0.7×	472 0.3×	1.6k 1.1×	178	6.5k
Shai Izraeli Israel	42	1.9k 0.5×	1.7k 0.5×	2.6k 1.2×	967 0.6×	885 0.6×	176	5.7k
K. Hählen Netherlands	39	2.4k 0.6×	2.1k 0.6×	908 0.4×	938 0.6×	612 0.4×	84	4.1k
Mats Heyman Sweden	39	2.6k 0.7×	1.3k 0.3×	1.3k 0.6×	1.9k 1.2×	984 0.7×	152	4.6k
Gregory A. Hale United States	40	1.0k 0.3×	2.5k 0.7×	671 0.3×	832 0.5×	1.5k 1.0×	133	5.3k

Countries citing papers authored by Frederick G. Behm

Since Specialization

Citations

This map shows the geographic impact of Frederick G. Behm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick G. Behm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick G. Behm more than expected).

Fields of papers citing papers by Frederick G. Behm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick G. Behm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick G. Behm. The network helps show where Frederick G. Behm may publish in the future.

Co-authorship network of co-authors of Frederick G. Behm

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick G. Behm. A scholar is included among the top collaborators of Frederick G. Behm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick G. Behm. Frederick G. Behm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mohapatra, Gayatry, et al.. (2024). Identification of unique genomic signatures in patients with fibromyalgia and chronic pain. Scientific Reports. 14(1). 3949–3949. 6 indexed citations

Acosta, Andrés, Shivangi Agarwal, Mohamed Rizwan Haroon Al Rasheed, et al.. (2023). In-Depth Comparison of Genetic Variants Demonstrates a Close Relationship Between Invasive and Intraductal Components of Prostate Cancer. Modern Pathology. 36(6). 100130–100130. 2 indexed citations

Chen, Zhengjia, et al.. (2022). Utilization of cytologic cell blocks for targeted sequencing of solid tumors. Cancer Medicine. 12(4). 4042–4063. 3 indexed citations

Behm, Frederick G., Igor M. Gavin, Valerie Lindgren, et al.. (2012). Unique immunologic patterns in fibromyalgia. BMC Clinical Pathology. 12(1). 25–25. 50 indexed citations

Coustan‐Smith, Elaine, Charles G. Mullighan, Mihaela Onciu, et al.. (2009). Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. The Lancet Oncology. 10(2). 147–156. 616 indexed citations breakdown →

Raimondi, Susana C., Yinmei Zhou, Sheila Shurtleff, et al.. (2006). Near-triploidy and near-tetraploidy in childhood acute lymphoblastic leukemia: association with B-lineage blast cells carrying the ETV6–RUNX1 fusion, T-lineage immunophenotype, and favorable outcome. Cancer Genetics and Cytogenetics. 169(1). 50–57. 25 indexed citations

Chen, Xiaohua, Gregory A. Hale, Raymond Barfield, et al.. (2006). Rapid immune reconstitution after a reduced‐intensity conditioning regimen and a CD3‐depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. British Journal of Haematology. 135(4). 524–532. 71 indexed citations

Coustan‐Smith, Elaine, Raul C. Ribeiro, Jeffrey E. Rubnitz, et al.. (2003). Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia. British Journal of Haematology. 123(2). 243–252. 94 indexed citations

Kuefer, Martin U., Vandana Chinwalla, Nancy J. Zeleznik‐Le, et al.. (2003). Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14). Oncogene. 22(9). 1418–1424. 18 indexed citations

10.

Blanco, Javier G., Mathew J. Edick, Michael L. Hancock, et al.. (2002). Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. Pharmacogenetics. 12(8). 605–611. 77 indexed citations

11.

Onciu, Mihaela, Robert B. Lorsbach, Emmanuelle Henry, & Frederick G. Behm. (2002). Terminal Deoxynucleotidyl Transferase–Positive Lymphoid Cells in Reactive Lymph Nodes From Children With Malignant Tumors. American Journal of Clinical Pathology. 118(2). 248–254. 21 indexed citations

12.

Bonilla, Miguel, Neyssa Marina, Sheila Shurtleff, et al.. (2000). Acute Lymphoblastic Leukemia in a Developing Country: Preliminary Results of a Nonrandomized Clinical Trial in El Salvador. The American journal of pediatric hematology/oncology. 22(6). 495–501. 74 indexed citations

13.

Campana, Dario & Frederick G. Behm. (2000). Immunophenotyping of leukemia. Journal of Immunological Methods. 243(1-2). 59–75. 118 indexed citations

14.

Ross, John F., Hui Wang, Frederick G. Behm, et al.. (1999). Folate receptor type ? is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer. 85(2). 348–357. 196 indexed citations

15.

Chen, Chun‐Lin, Michael H. Woo, Geoffrey Neale, et al.. (1998). A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 403(1-2). 113–125. 9 indexed citations

16.

Coustan‐Smith, Elaine, Frederick G. Behm, Joaquín Sánchez, et al.. (1998). Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. The Lancet. 351(9102). 550–554. 329 indexed citations

17.

Stewart, Carleton C., Frederick G. Behm, John L. Carey, et al.. (1997). U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations. Cytometry. 30(5). 231–235. 44 indexed citations

18.

Mahmoud, Hazem H., Gaston K. Rivera, Michael L. Hancock, et al.. (1993). Low Leukocyte Counts with Blast Cells in Cerebrospinal Fluid of Children with Newly Diagnosed Acute Lymphoblastic Leukemia. New England Journal of Medicine. 329(5). 314–319. 144 indexed citations

19.

Pombo‐de‐Oliveira, Maria S., Diane Fairclough, Craig A. Hurwitz, et al.. (1993). Acute Megakaryoblastic Leukemia in Children and Adolescents: A Retrospective Analysis of 24 Cases. Leukemia & lymphoma. 10(4-5). 299–306. 43 indexed citations

20.

Rosenblum, William I., et al.. (1985). Some long-term effects of exchange transfusion with fluorocarbon emulsions in macaque monkeys.. PubMed. 109(4). 340–4. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact